A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/095 (2006.01) A61K 39/02 (2006.01) A61K 39/102 (2006.01)
Patent
CA 2204277
A combined vaccine comprising a Haemophilus influenzae type B (Hib) oligosaccharide conjugate and a Neisseria meningitidis serogroup C (MenC) oligosaccharide conjugate. The combination vaccine is free from interference between the antigens used. The vaccine may also include a Neisseria meningitidis serogroup B (MenB) oligosaccharide conjugate. The vaccine may be used in the prophylaxis or treatment of bacterial meningitis and allows economical, safe and expedient vaccination against the prevalent causes of meningitis. Advantageously, carrier priming may be exploited in order to maximize response to the vaccine, for example using a diphtheria, pertussis and tetanus (DTP) vaccine. The oligosaccharides are preferably size-selected and advantageously have a degree of polymerization of 4 or more.
Un vaccin polyvalent contre la méningite d'origine bactérienne comprend des conjugués d'oligosaccharides Hib et MenC.
Ceccarini Costante
Costantino Paolo
D'ascenzi Sandro
Giannozzi Aldo
Norelli Francesco
Biocine S.p.a.
Borden Ladner Gervais Llp
Novartis Vaccines And Diagnostics S.r.l.
LandOfFree
Combined meningitis vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combined meningitis vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined meningitis vaccine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1409570